RecruitingNot applicableNCT06783816

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanxi Bethune Hospital
Intervention
chimeric antigen receptor gene modified T cells(drug)
Enrollment
45 enrolled
Eligibility
All sexes
Timeline
20232028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06783816 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials